Assignee
CANTLEY LEWIS C
US·2 granted patents·4 pending applications·38 citations·filing 2003–2022
Top patents by PatentIndex Score
6 records- 0190US8883438B2Method for diagnosing cell proliferation disorders having a neoactive mutation at residue 97 of isocitrate dehydrogenase 1CANTLEY LEWIS C·Filed 2012·Granted Nov 11, 2014·18 cites·12 claims
- 0287US8552050B2Activators of pyruvate kinase M2 and methods of treating diseaseCANTLEY LEWIS C·Filed 2008·Granted Oct 8, 2013·20 cites·4 claims
- 0358US2024167041A1Loss of lipid kinase pi5p4k gamma restricts tumor growthCANTLEY LEWIS C·Filed 2022·Application pending·0 cites
- 0443US2012122991A1Method for treating cancer by increasing amp-activated kinase activityCANTLEY LEWIS C·Filed 2012·Application pending·0 cites
- 0541US2013203618A1Methods and compositions for the diagnosis and treatment of cellular proliferative disordersCANTLEY LEWIS C·Filed 2011·Application pending·0 cites
- 0638US2006089320A1Modulation of type IIß phosphoinositide phosphate kinaseCANTLEY LEWIS C·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CANTLEY LEWIS C files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →